| Literature DB >> 32864935 |
Roman Komarov1, Alisher Ismailbaev1, Vagi Chragyan2, Bakytbek Kadyraliev2, Michel Pompeu B O Sá3, Arjang Ruhparwar4, Alexander Weymann4, Konstantin Zhigalov4.
Abstract
OBJECTIVE: To examine the results of various myocardial revascularization techniques in pediatric patients to better understand the strategies for surgical treatment of coronary artery pathologies.Entities:
Keywords: Arterial Switch Operation; Coronary Artery Bypass; Coronary Vessels; Heart Defects, Congenital; Iatrogenic Disease; Mammary Arteries; Mucocutaneous Lymph Node Syndrome; Myocardial Revascularization; Pulmonary Artery; Transposition of Great Vessels
Mesh:
Year: 2020 PMID: 32864935 PMCID: PMC7454630 DOI: 10.21470/1678-9741-2019-0366
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Fig. 1Main indications for pediatric coronary artery bypass grafting (CABG) surgery. LCA=left coronary artery
Best evidence publications for pediatric coronary artery bypass grafting (PCABG).
| Author (date), journal, country and study type | Patient group | Key results | Conclusions |
|---|---|---|---|
| Kitamura et al.[ | 114 patients who underwent PCABG for KD using ITA and saphenous vein grafts. | No in-hospital mortality. 25-year survival rate - 95%. | PCABG for KD showed excellent long-term outcomes. |
| Vida et al.[ | 80 patients from 13 centers who underwent PCABG and other coronary artery procedures between 1973 and 2011. KD patients were excluded. | In-hospital mortality - 15% (12 patients). | PCABG is a suitable surgical option in pediatric patients with impaired myocardial perfusion, which increases mid-term survival. Life-long FU needed to prevent and treat any further coronary/myocardial complications. |
| Legendre et al.[ | 18 patients who underwent PCABG using LITA and/or RITA between 1988 and 2007. | No in-hospital mortality. | PCABG should be considered as a possible alternative for coronary revascularization. This procedure remains a technical challenge and requires careful FU. |
| Mavroudis et al.[ | 16 patients who underwent PCABG using LITA and/or RITA for KD, congenital lesions, post arterial switch, and other iatrogenic obstructions between 1987 and 1998. | Overall survival - 93.8% (15 patients). | PCABG using ITA can be successfully performed in infants and children for expanding elective and life-saving indications with excellent results. |
CI=confidence interval; FU=follow-up; ITA=internal thoracic artery; KD=Kawasaki disease; LITA=left internal thoracic artery; RITA=right internal thoracic artery
Fig. 2Giant aneurysm of the left coronary artery trunk in a 7-year-old child with Kawasaki disease.
Fig. 3Intraoperative coronary angiogram of anterior descending artery (ADA) grafting using left internal thoracic artery (LITA) in a 7-year-old child with Kawasaki disease.
Fig. 4The longitudinal growth of the internal thoracic artery in accordance with the somatic development of the child from 1 month to 7 years after coronary artery bypass grafting. The growth potential is obvious, without any degenerative changes in the graft wall.
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| ADA | = Anterior descending artery | KD | = Kawasaki disease | |
| ALCAPA | = Anomalous origin of the left coronary artery from the pulmonary artery | LAD | = Left anterior descending artery | |
| BWGS | = Bland-White-Garland syndrome | LCA | = Left coronary artery | |
| CABG | = Coronary artery bypass grafting | LITA | = Left internal thoracic artery | |
| CAD | = Coronary artery disease | LVEF | = Left ventricular ejection fraction | |
| CHD | = Congenital heart disease | PCABG | = Pediatric coronary artery bypass grafting | |
| CI | = Confidence interval | PCI | = Percutaneous coronary intervention | |
| FFR | = Fractional flow reserve | RCA | = Right coronary artery | |
| FU | = Follow-up | RITA | = Right internal thoracic artery | |
| ITA | = Internal thoracic artery | TGA | = Transposition of the great arteries | |
| Authors' roles & responsibilities | |
|---|---|
| RK | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| AI | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| VC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| BK | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| MPBOS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| AR | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| AW | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| KZ | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |